Upcoming Visits

Upcoming FDA Visits:

Dates Topic FDA Visitors

August 2017

 

CRISPR/Cas9 Genome Editing

 

Jakob Reiser, PhD | Principal Investigator, Division of Cellular & Gene Therapies/OTAT, CBER
Ying Huang, PhD| Pharmacologist, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER

 

September 2017

 

Oncology Products

Geoffrey Kim, MD | Director, Division of Oncology Products 1/OHOP, CDER

 

September 2017

Cellular Immunotherapies

Graeme Price, PhD | Research Microbiologist, Division of Cellular & Gene Therapies/OTAT, CBER
Kristin Baird, MD | Medical Officer, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER

 

Public lectures are posted under the "Events" link on the left menu bar.  Please contact Lawrence Lin to learn more about any of the upcoming visits.